TECHBio-Techne

Health care · Biotechnology · Nasdaq

Headquarters: Minneapolis, MN
CEO: Kim Kelderman
Next results: around Feb 3, 2027

TECH and 9 peers, year by year

The 9 Health care companies closest to TECH in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
TECH Bio-Techne	FY2026	$1.2B	−0.4%	65.8%	20.7%	15.0%	21.7%	8.6%	0.09
MRNA Moderna	FY2025	$1.9B	−39.9%	-	−158.1%	−145.2%	−106.2%	−32.6%	0.07
RVTY Revvity	FY2025	$2.9B	+3.7%	-	12.5%	8.4%	17.8%	3.3%	0.44
PODD Insulet Corporation	FY2025	$2.7B	+30.7%	71.6%	17.5%	9.1%	13.9%	16.3%	0.63
WST West Pharmaceutical Services	FY2025	$3.1B	+6.3%	35.9%	19.0%	16.1%	15.3%	15.5%	0.06
VEEV Veeva Systems	FY2026	$3.2B	+16.3%	75.5%	28.7%	28.4%	-	12.6%	-
CRL Charles River Laboratories	FY2025	$4.0B	−0.9%	-	0.6%	−3.6%	12.9%	−4.6%	0.68
ALGN Align Technology	FY2025	$4.0B	+0.9%	67.2%	13.5%	10.2%	12.2%	10.1%	-
MTD Mettler Toledo	FY2025	$4.0B	+4.0%	59.4%	-	21.6%	21.1%	n/m	n/m
COO Cooper Companies	FY2025	$4.1B	+5.1%	65.5%	16.7%	9.2%	10.6%	4.6%	0.30

Revenuepeer median $3.2B

Sales growthpeer median +4.0%

Gross marginpeer median 66.4%

Operating marginpeer median 15.1%

Net marginpeer median 9.2%

FCF marginpeer median 13.4%

Return on equitypeer median 7.3%

Debt / equitypeer median 0.37

CRL 0.68
PODD 0.63
RVTY 0.44
COO 0.30
TECH 0.09
MRNA 0.07
WST 0.06
VEEV -
ALGN -
MTD n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2017 to FY2026

Revenue as reported in the 10-K.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	$563.0M	$643.0M	$714.0M	$738.7M	$931.0M	$1.1B	$1.1B	$1.2B	$1.2B	$1.2B
MRNA Dec	$205.8M	$135.1M	$60.2M	$803.0M	$18.5B	$19.3B	$6.8B	$3.2B	$1.9B	-
RVTY Dec	$2.3B	$2.8B	$2.9B	$3.8B	$3.8B	$3.3B	$2.8B	$2.8B	$2.9B	-
PODD Dec	$463.8M	$563.8M	$738.2M	$904.4M	$1.1B	$1.3B	$1.7B	$2.1B	$2.7B	-
WST Dec	$1.6B	$1.7B	$1.8B	$2.1B	$2.8B	$2.9B	$2.9B	$2.9B	$3.1B	-
VEEV Jan	$550.5M	$690.6M	$862.2M	$1.1B	$1.9B	-	$2.2B	$2.4B	$2.7B	$3.2B
CRL Dec	$1.9B	$2.3B	$2.6B	$2.9B	$3.5B	$4.0B	$4.1B	$4.0B	$4.0B	-
ALGN Dec	$1.5B	$2.0B	$2.4B	$2.5B	$4.0B	$3.7B	$3.9B	$4.0B	$4.0B	-
MTD Dec	$2.7B	$2.9B	$3.0B	$3.1B	$3.7B	$3.9B	$3.8B	$3.9B	$4.0B	-
COO Oct	$2.1B	$2.5B	$2.7B	$2.4B	$2.9B	$3.3B	$3.6B	$3.9B	$4.1B	-
Peer median	$1.6B	$2.0B	$2.4B	$2.4B	$3.5B	$3.5B	$3.6B	$3.2B	$3.1B	-

Sales growth, FY2017 to FY2026

Revenue against the fiscal year before.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	+12.8%	+14.2%	+11.0%	+3.5%	+26.0%	+18.7%	+2.8%	+2.0%	+5.2%	−0.4%
MRNA Dec	+89.9%	−34.4%	−55.4%	n/m	n/m	+4.3%	−64.4%	−52.7%	−39.9%	-
RVTY Dec	+6.7%	+23.1%	+3.8%	+31.2%	+43.7%	−13.5%	−16.9%	+0.2%	+3.7%	-
PODD Dec	+26.4%	+21.6%	+30.9%	+22.5%	+15.1%	+18.8%	+30.0%	+22.1%	+30.7%	-
WST Dec	+6.0%	+7.4%	+7.1%	+16.7%	+31.9%	+2.0%	+2.2%	−1.9%	+6.3%	-
VEEV Jan	+32.9%	+25.4%	+24.9%	+28.1%	+26.3%	-	+16.4%	+9.7%	+16.2%	+16.3%
CRL Dec	+10.5%	+22.0%	+15.7%	+11.5%	+21.1%	+12.3%	+3.9%	−1.9%	−0.9%	-
ALGN Dec	+36.4%	+33.5%	+22.4%	+2.7%	+59.9%	−5.5%	+3.4%	+3.5%	+0.9%	-
MTD Dec	+8.6%	+7.7%	+2.5%	+2.5%	+20.5%	+5.4%	−3.4%	+2.2%	+4.0%	-
COO Oct	+8.8%	+18.4%	+4.8%	−8.4%	+20.2%	+13.2%	+8.6%	+8.4%	+5.1%	-
Peer median	+10.5%	+21.6%	+7.1%	+14.1%	+23.7%	+4.9%	+3.4%	+2.2%	+4.0%	-

Gross margin, FY2017 to FY2026

Gross profit / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	66.5%	67.2%	66.3%	65.4%	68.0%	68.4%	67.7%	66.4%	64.8%	65.8%
MRNA Dec	-	-	-	-	-	-	-	-	-	-
RVTY Dec	47.6%	48.3%	48.4%	55.8%	63.6%	60.1%	-	-	-	-
PODD Dec	59.8%	65.7%	65.1%	64.4%	68.4%	61.7%	68.3%	69.8%	71.6%	-
WST Dec	32.1%	31.8%	32.9%	35.8%	41.5%	39.4%	38.3%	34.5%	35.9%	-
VEEV Jan	68.5%	69.4%	71.6%	72.5%	72.8%	-	71.7%	71.3%	74.5%	75.5%
CRL Dec	-	-	-	-	-	-	-	-	-	-
ALGN Dec	75.8%	73.6%	72.5%	71.3%	74.3%	70.5%	70.1%	70.0%	67.2%	-
MTD Dec	57.8%	57.4%	57.9%	58.4%	58.4%	58.9%	59.2%	60.1%	59.4%	-
COO Oct	63.9%	64.4%	66.2%	63.1%	66.9%	64.7%	65.6%	66.6%	65.5%	-
Peer median	59.8%	64.4%	65.1%	63.1%	66.9%	60.9%	67.0%	68.2%	66.4%	-

Operating margin, FY2017 to FY2026

Operating income / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	21.4%	21.2%	20.5%	21.3%	25.5%	26.8%	26.3%	17.8%	8.4%	20.7%
MRNA Dec	−130.9%	−306.0%	−906.8%	−95.0%	72.0%	48.9%	−61.9%	−121.9%	−158.1%	-
RVTY Dec	13.1%	11.7%	12.6%	22.9%	32.9%	22.4%	10.9%	12.6%	12.5%	-
PODD Dec	−1.6%	4.9%	6.8%	5.7%	11.5%	2.9%	13.0%	14.9%	17.5%	-
WST Dec	14.1%	14.0%	16.1%	19.0%	26.6%	25.4%	22.9%	19.7%	19.0%	-
VEEV Jan	21.9%	22.9%	25.8%	25.9%	27.3%	-	21.3%	18.2%	25.2%	28.7%
CRL Dec	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	5.6%	0.6%	-
ALGN Dec	24.0%	23.7%	22.5%	15.7%	24.7%	17.2%	16.7%	15.2%	13.5%	-
MTD Dec	-	-	-	-	-	-	-	-	-	-
COO Oct	20.1%	15.9%	20.6%	12.8%	17.3%	15.3%	14.8%	18.1%	16.7%	-
Peer median	14.8%	14.3%	14.8%	15.2%	25.6%	17.2%	14.9%	15.1%	15.1%	-

Net margin, FY2017 to FY2026

Net income / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	13.5%	19.6%	13.5%	31.0%	15.1%	24.6%	25.1%	14.5%	6.0%	15.0%
MRNA Dec	−124.3%	−284.8%	−853.7%	−93.0%	66.1%	43.4%	−68.8%	−110.0%	−145.2%	-
RVTY Dec	13.0%	8.6%	7.9%	19.2%	24.6%	17.2%	25.2%	9.8%	8.4%	-
PODD Dec	−5.8%	0.6%	1.6%	0.8%	1.5%	0.4%	12.2%	20.2%	9.1%	-
WST Dec	9.4%	12.0%	13.1%	16.1%	23.4%	20.3%	20.1%	17.0%	16.1%	-
VEEV Jan	14.1%	21.9%	26.7%	27.3%	23.1%	-	22.6%	22.2%	26.0%	28.4%
CRL Dec	6.6%	10.0%	9.6%	12.5%	11.0%	12.2%	11.5%	0.5%	−3.6%	-
ALGN Dec	15.7%	20.4%	18.4%	71.8%	19.5%	9.7%	11.5%	10.5%	10.2%	-
MTD Dec	13.8%	17.5%	18.6%	19.5%	20.7%	22.3%	20.8%	22.3%	21.6%	-
COO Oct	17.4%	5.5%	17.6%	9.8%	100.8%	11.7%	8.2%	10.1%	9.2%	-
Peer median	13.0%	10.0%	13.1%	16.1%	23.1%	14.7%	12.2%	10.5%	9.2%	-

Free cash flow, FY2017 to FY2026

Cash from operations minus capital spending.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	$128.5M	$149.4M	$156.2M	$153.5M	$307.9M	$280.4M	$216.1M	$236.1M	$256.6M	$263.2M
MRNA Dec	−$389.9M	−$436.6M	−$491.0M	$2.0B	$13.3B	$4.6B	−$3.8B	−$4.1B	−$2.1B	-
RVTY Dec	$249.4M	$217.8M	$287.1M	$828.5M	$1.3B	$594.2M	$9.9M	$541.7M	$509.4M	-
PODD Dec	−$32.5M	−$121.5M	−$65.3M	−$45.0M	−$180.0M	−$3.9M	$70.1M	$305.3M	$377.7M	-
WST Dec	$132.5M	$183.9M	$240.8M	$298.1M	$330.6M	$439.4M	$414.5M	$276.4M	$468.9M	-
VEEV Jan	$137.1M	$223.8M	$302.4M	$434.3M	-	-	-	-	-	-
CRL Dec	$235.6M	$301.1M	$340.4M	$380.0M	$532.0M	$294.9M	$365.4M	$501.6M	$518.5M	-
ALGN Dec	$242.8M	$331.4M	$597.6M	$507.3M	$771.4M	$276.8M	$608.1M	$622.7M	$490.8M	-
MTD Dec	$388.9M	$422.3M	$506.1M	$632.2M	$801.2M	$737.8M	$860.6M	$864.4M	$848.6M	-
COO Oct	$466.4M	$475.3M	$421.1M	$176.2M	$524.2M	$450.4M	$215.0M	$288.1M	$433.7M	-
Peer median	$235.6M	$223.8M	$302.4M	$434.3M	$651.7M	$444.9M	$290.2M	$403.5M	$479.8M	-

FCF margin, FY2017 to FY2026

Free cash flow / revenue.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	22.8%	23.2%	21.9%	20.8%	33.1%	25.4%	19.0%	20.4%	21.0%	21.7%
MRNA Dec	−189.4%	−323.3%	−815.5%	244.0%	72.2%	23.8%	−55.9%	−125.3%	−106.2%	-
RVTY Dec	11.0%	7.8%	10.0%	21.9%	34.6%	17.9%	0.4%	19.7%	17.8%	-
PODD Dec	−7.0%	−21.6%	−8.8%	−5.0%	−16.4%	−0.3%	4.1%	14.7%	13.9%	-
WST Dec	8.3%	10.7%	13.1%	13.9%	11.7%	15.2%	14.1%	9.6%	15.3%	-
VEEV Jan	24.9%	32.4%	35.1%	39.3%	-	-	-	-	-	-
CRL Dec	12.7%	13.3%	13.0%	13.0%	15.0%	7.4%	8.8%	12.4%	12.9%	-
ALGN Dec	16.5%	16.9%	24.8%	20.5%	19.5%	7.4%	15.7%	15.6%	12.2%	-
MTD Dec	14.3%	14.4%	16.8%	20.5%	21.6%	18.8%	22.7%	22.3%	21.1%	-
COO Oct	21.8%	18.8%	15.9%	7.2%	17.9%	13.6%	6.0%	7.4%	10.6%	-
Peer median	12.7%	13.3%	13.1%	20.5%	18.7%	14.4%	7.4%	13.6%	13.4%	-

Return on equity, FY2017 to FY2026

Net income / shareholders' equity at the year end.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	8.0%	11.7%	8.2%	16.6%	9.0%	16.0%	14.5%	8.1%	3.8%	8.6%
MRNA Dec	n/m	−25.1%	−43.7%	−29.2%	86.3%	43.7%	−34.0%	−32.7%	−32.6%	-
RVTY Dec	11.7%	9.2%	8.1%	19.5%	13.2%	7.7%	8.8%	3.5%	3.3%	-
PODD Dec	−16.9%	1.6%	15.3%	1.1%	3.0%	1.0%	28.2%	34.5%	16.3%	-
WST Dec	11.8%	14.8%	15.4%	18.7%	28.3%	21.8%	20.6%	18.4%	15.5%	-
VEEV Jan	11.4%	16.7%	18.6%	18.1%	14.7%	-	13.1%	11.3%	12.2%	12.6%
CRL Dec	11.8%	17.2%	15.4%	17.2%	15.4%	16.3%	13.2%	0.6%	−4.6%	-
ALGN Dec	20.0%	31.9%	32.9%	54.9%	21.3%	10.0%	12.3%	10.9%	10.1%	-
MTD Dec	68.7%	86.9%	133.3%	n/m	n/m	n/m	n/m	n/m	n/m	-
COO Oct	11.7%	4.2%	12.9%	6.2%	42.4%	5.4%	3.9%	4.9%	4.6%	-
Peer median	11.8%	14.8%	15.4%	17.7%	18.4%	10.0%	12.7%	7.9%	7.3%	-

Debt / equity, FY2017 to FY2026

Total debt / shareholders' equity at the year end.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	0.36	0.31	0.43	0.26	0.22	0.15	0.18	0.15	0.18	0.09
MRNA Dec	-	-	-	-	-	-	-	0.00	0.07	-
RVTY Dec	0.80	0.73	0.74	0.53	0.70	0.60	0.50	0.41	0.44	-
PODD Dec	3.57	2.79	11.70	1.75	2.29	2.94	1.93	1.14	0.63	-
WST Dec	0.15	0.14	0.16	0.14	0.11	0.08	0.07	0.08	0.06	-
VEEV Jan	-	-	-	-	-	-	-	-	-	-
CRL Dec	1.04	1.22	1.15	0.93	1.05	0.91	0.74	0.65	0.68	-
ALGN Dec	-	-	-	-	-	-	-	-	-	-
MTD Dec	1.79	1.75	3.07	4.72	9.81	n/m	n/m	n/m	n/m	-
COO Oct	0.37	0.61	0.50	0.47	0.21	0.38	0.34	0.32	0.30	-
Peer median	0.92	0.98	0.95	0.73	0.87	0.60	0.50	0.37	0.37	-

EPS (diluted), FY2017 to FY2026

Diluted earnings per share, on today's share count after splits.

Company	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
TECH Jun	$0.51	$0.83	$0.62	$1.46	$0.87	$1.66	$1.76	$1.05	$0.46	$1.16
MRNA Dec	−$4.18	−$4.95	−$1.55	−$1.96	$28.29	$20.12	−$12.33	−$9.28	−$7.26	-
RVTY Dec	$2.64	$2.13	$2.04	$6.49	$8.08	$4.50	$5.55	$2.20	$2.07	-
PODD Dec	−$0.46	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78	$3.48	-
WST Dec	$1.99	$2.74	$3.21	$4.57	$8.67	$7.73	$7.88	$6.69	$6.79	-
VEEV Jan	$0.53	$0.98	$1.47	$1.90	$2.63	-	$3.00	$3.22	$4.32	$5.44
CRL Dec	$2.54	$4.62	$5.07	$7.20	$7.60	$9.48	$9.22	$0.20	−$2.91	-
ALGN Dec	$2.83	$4.92	$5.53	$22.41	$9.69	$4.61	$5.81	$5.62	$5.65	-
MTD Dec	$14.24	$19.88	$22.47	$24.91	$32.78	$38.41	$35.90	$40.48	$42.05	-
COO Oct	$1.88	$0.70	$2.33	$1.20	$14.79	$1.94	$1.48	$1.96	$1.87	-
Peer median	$1.99	$2.13	$2.33	$4.57	$8.67	$6.17	$5.55	$3.22	$3.48	-

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out TECH and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on TECH in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/TECH/export.csv") into a cell.